Processa Pharmaceuticals
PCSA
PCSA
22 hedge funds and large institutions have $853K invested in Processa Pharmaceuticals in 2023 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 4 increasing their positions, 3 reducing their positions, and 4 closing their positions.
Holders
22
Holders Change
+4
Holders Change %
+22.22%
% of All Funds
0.35%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
4
Reduced
3
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
Walleye Capital
New York
|
$389K |
| 2 |
TSS
2
Two Sigma Securities
New York
|
$31.3K |
| 3 |
3
Millennium Management
New York
|
$27K |
| 4 |
4
UBS Group
Zurich,
Switzerland
|
$11.2K |
| 5 |
5
Renaissance Technologies
New York
|
$16K |
